Global Clinical Coverage Leverage ACM Global Laboratories' presence in 65+ countries and fully owned facilities in the USA, UK, India, and Singapore to pitch expansion-focused partnerships, joint ventures, or multi-region clinical trial testing services for sponsors seeking global reach and standardized central lab operations.

High Throughput Testing Capitalize on the capability to perform over 20 million tests annually across pathology, microbiology, molecular diagnostics, and toxicology to offer scalable, end-to-end laboratory services for large-scale clinical trials and post-market surveillance programs.

Affiliation Advantage Highlight ACM’s status as an affiliate of Rochester Regional Health to position as a financially stable, quality-driven partner with access to broad clinical expertise, regulatory support, and established healthcare networks that can de-risk complex studies.

Vaccine and Therapeutics Focus Target opportunities in COVID-19 vaccine studies and infectious disease therapeutic trials, given historic involvement in vaccine study launches and therapeutic service offerings, and offer end-to-end trial optimization and real-world safety monitoring capabilities.

Data and Analytics Edge Promote the use of advanced analytics and reporting tools (Power BI, Hyperion, New Relic) as a differentiator for trial data management, performance dashboards, and rapid decision-making to sponsors seeking transparent, data-driven trial oversight.